Inside Stanford's virtual biotech: 37,000 AI agents, no humans, full drug pipeline
Dr_Singularity · x · 2026-09-20
Stanford Medicine details how James Zou's lab, with graduate student Harrison Zhang, spun out a virtual biotech company from its 2025 virtual lab: 37,000 employees, all AI agents covering the full pipeline from target discovery to clinical trial design, with no lab space or payroll. The AI company predicted drug trial success and independently designed a lung cancer therapy later validated in trials.
More from AGI Musings
- Newsweek op-ed: US should fund hospitals and universities in federated AI learning — Saul_Loveman · 2026-11-12
- 10-line deterministic polynomial-time primality test relies on OpenAI's recent quasi-GRH result, making AKS obsolete — fortnow · 2026-11-11
- AI2027 Author Kokotajlo Shifts AGI Median Timeline to Around 2030 — JacquesThibs · 2026-11-11
- Ron Bodkin: automated research taste advances faster than expected, but the evidence is weak — ronbodkin · 2026-11-11
- Should devs still hand-write code? Author proposes 1,000-hour baseline before AI agents — bendee983 · 2026-11-11
- DEF CON panel with Bruce Schneier and Google security VP posted: scaling laws and open weights — JasonDClinton · 2026-11-11